Trevi Therapeutics, Inc. (TRVI) Deferred Tax Assets, Valuation Allowance USD 2018 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Trevi Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2018 to 2023.
  • Trevi Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $69.5 M, a 13.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $69.5 M +$8.43 M +13.8% Dec 31, 2023 10-K 2024-03-20
Q4 2022 $61.1 M +$8.38 M +15.9% Dec 31, 2022 10-K 2024-03-20
Q4 2021 $52.7 M +$9.87 M +23% Dec 31, 2021 10-K 2023-03-16
Q4 2020 $42.8 M +$9.53 M +28.6% Dec 31, 2020 10-K 2022-03-17
Q4 2019 $33.3 M +$7.36 M +28.4% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $25.9 M Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.